Article Listing - HOUSTON'S IMMUNOTOXIN TRIAL GETS GO-AHEAD

RU's DIMETROSE FOR CYCLIC MASTALGIA

3 February 1992

A multicenter study investigating the applicability and safety of Roussel Uclaf's Dimetrose (gestrinone) as a treatment for women with cyclical...

PROTEUS INTERNATIONAL "PROCEEDING TO PLAN"

3 February 1992

The six months to September 1991 saw continuing developments for UK computer-aided molecular modelling and drug design company Proteus International....

WYETH AYERST/ TLC FLU VACCINE DEAL

3 February 1992

Wyeth-Ayerst Laboratories, a division of American Home Products, has entered into an agreement with The Liposome Company concerning the development...

ROBERTS' SOMAGARD APPROVED IN EIRE

3 February 1992

Roberts Pharmaceutical Corporation has been granted marketing approval by the Republic of Ireland's regulatory authorities for its prostate cancer treatment...

VESTAR'S AMBISOME LAUNCHED IN THE UK

3 February 1992

The first liposomal formulation of a drug has now been launched in the UK, in the form of Vestar's Ambisome,...

STOCK MARKET COMMENTARY: TOKYO

3 February 1992

TOKYO: closed with a 0.4% gain at 21,007.11 yen after a volatile trading week dominated by index and futures- linked...

STOCK MARKET COMMENTARY: EUROPE

3 February 1992

EUROPE: saw ups and downs on the reporting week, with Belgium, Germany and Switzerland the strongest stock markets. FRANKFURT saw...

GOOD 1991 RESULTS FOR MERCK AND FOREST LABS

3 February 1992

Fourth quarter and 1991 year-end financial results announced in the USA over the past week were led by the generics...

DU PONT'S JOHN KROL

3 February 1992

- John Krol has been named as a vice chairman and director of Du Pont Co.

APPOINTMENTS AT BRISTOL-MYERS SQUIBB

3 February 1992

- At Bristol-Myers Squibb Co, Wesley Thompson has been appointed president of the Bristol-Myers Squibb Consumer Products International division....

Showing 94841-94850 of 95333 articles